Director/PDMR Shareholding

RNS Number : 5773D

Hikma Pharmaceuticals Plc

03 March 2022

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Douglas Hurt
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Market purchase of 1,500 Ordinary Shares by Gillian Hurt, spouse of Douglas Hurt
c)	Price(s) and volume(s)	Price(s): £19.54 Volume(s): 1,500
d)	Aggregated information -  Volume -  Price -  Total	1,500 £19.54 £29,310
e)	Date of the transaction	3 March 2022
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs, Company Secretary, responsible for releasing this announcement
[phone]

3 March 2022

 

END

 

 

DSHBSGDXXSGDGDX